A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers
Phase 1
Completed
- Conditions
- Asthma
- Interventions
- Drug: Z7200 without oral activated charcoalDrug: Symbicort Turbohaler without oral activated charcoalDrug: Z7200 with oral activated charcoalDrug: Symbicort Turbohaler with oral activated charcoal
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2022-02-23
- Lead Sponsor
- Zambon SpA
- Target Recruit Count
- 90
- Registration Number
- NCT02237508
- Locations
- 🇬🇧
Quotient Clinical Ltd, Ruddington, United Kingdom
Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients
Phase 2
Completed
- Conditions
- Asthma BronchialAsthma ChronicAsthmaticAsthma
- Interventions
- Drug: Z7200Drug: Symbicort® Turbohaler®
- First Posted Date
- 2014-08-28
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- Zambon SpA
- Target Recruit Count
- 20
- Registration Number
- NCT02227394
- Locations
- 🇧🇪
Antwerp University Hospital, Edegem, Antwerp, Belgium
Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Zambon SpA
- Target Recruit Count
- 184
- Registration Number
- NCT00639496
- Locations
- 🇧🇪
U.Z. Ghent, Gent, Belgium
🇫🇷Hôpital A. Calmette, Lille Cedex, France
🇩🇪Klinikum Grosshadern, Munich, Germany
© Copyright 2025. All Rights Reserved by MedPath